Health Care Technology
Company Overview of WellDoc, Inc.
WellDoc, Inc. is a health care behavioral science and technology company that develops technology solutions to support chronic disease management. It provides DiabetesManager, an intelligent, data driven, and patient centric platform that enables patients and health care providers to coordinate diabetes care, propel self-management, and achieve long-term adherence. The company’s DiabetesManager platform features personalized and real-time patient coaching, testing and medication reminders, out of bound alerts, and metabolic target ranges; family and community connectivity, and caregiver alerts and support; cloud-based analytics, evidence-based guidelines, longitudinal tracking, and event/ale...
1501 Saint Paul Street
Baltimore, MD 21202
Founded in 2005
Key Executives for WellDoc, Inc.
Co-Founder and Chief Medical Officer
Vice President of Operations
Compensation as of Fiscal Year 2016.
WellDoc, Inc. Key Developments
WellDoc Appoints Nick Harsh as Vice President, Market Access
Apr 5 16
WellDoc announced that Nick Harsh has joined the company as Vice President, Market Access. In this new role, Mr. Harsh will be responsible for leading the company's payer strategy, relationships and execution. Over the last 15 years, Mr. Harsh been a part of the management team for the AstraZeneca organization, launching and supporting several AstraZeneca and MedImmune well-recognized brands, including Nexium®, Crestor® and FluMist ®. Most recently, he led the commercial strategy, pricing, operations, and channel distribution services for MedImmune’s specialty biologics.
Cilag GmbH International Announces Strategic Collaboration with WellDoc Corporation to Advance Mobile Care Solutions for Type 2 Diabetes Patients
Mar 1 16
LifeScan, Inc. announced a strategic collaboration through its affiliate Cilag GmbH International with WellDoc Corporation to advance mobile solutions that can empower Type 2 diabetes patients with real time data and information to improve their health outcomes. Through the collaboration both companies will work to integrate LifeScan's newly launched OneTouch Verio Flex blood glucose monitoring system with built-in Bluetooth Smart Technology and OneTouch Reveal mobile application with WellDoc's BlueStar diabetes management platform and mobile application, the first mobile prescription therapy approved by the U.S. Food and Drug Administration for Type 2 diabetes. OneTouch Verio Flex features ColorSure technology – a simple, accurate and easy-to-use meter that takes the guesswork out of understanding blood sugar test results for people with diabetes. The integration would provide patients additional smart monitoring tools and real-time motivational, behavioral and educational coaching, which clinical studies have shown improve patient health.
WellDoc, Inc. Presents at 8th Annual Biotech Showcase Investor Conference 2016, Jan-13-2016 08:00 AM
Dec 8 15
WellDoc, Inc. Presents at 8th Annual Biotech Showcase Investor Conference 2016, Jan-13-2016 08:00 AM. Venue: Parc 55 San Francisco, 55 Cyril Magnin Street, San Francisco, CA 94102, United States. Speakers: Kevin P. McRaith, Chief Executive Officer.
Similar Private Companies By Industry
Recent Private Companies Transactions
December 16, 2015
July 28, 2015